Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-055203

10% owner sold 48,640 shares at an average $29.20 ($1,420,394)

From the SEC's structured data for this filing

Trades in this filing

UBS Oncology Impact Fund L.P. · 10% owner

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-03 Sale : show line 1 in the form −12,731 $29.60 $376,838 7,724,085 D
2021-09-07 Sale : show line 2 in the form −25,067 $29.04 $727,946 7,699,018 D
2021-09-08 Sale : show line 3 in the form −10,842 $29.11 $315,611 7,688,176 D
Open-market sales · 48,640 sh · avg $29.20 · $1,420,394
Loading xslF345X03/doc4.xml…